Form 8-K - Current report:
SEC Accession No. 0001839882-24-001450
Filing Date
2024-01-19
Accepted
2024-01-19 08:00:30
Documents
12
Period of Report
2024-01-19
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT rain_8k-011924.htm   iXBRL 8-K 46870
  Complete submission text file 0001839882-24-001450.txt   231726

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE rain-20240119.xsd EX-101.SCH 3027
3 XBRL LABEL FILE rain-20240119_lab.xml EX-101.LAB 34916
4 XBRL PRESENTATION FILE rain-20240119_pre.xml EX-101.PRE 22797
6 EXTRACTED XBRL INSTANCE DOCUMENT rain_8k-011924_htm.xml XML 3556
Mailing Address 8000 JARVIS AVENUE SUITE 204 NEWARK CA 94560
Business Address 8000 JARVIS AVENUE SUITE 204 NEWARK CA 94560 (510) 953-5559
Rain Oncology Inc. (Filer) CIK: 0001724979 (see all company filings)

EIN.: 821130967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40356 | Film No.: 24543773
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)